SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-23-015972
Filing Date
2023-05-09
Accepted
2023-05-09 17:00:41
Documents
55
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form6-k.htm   iXBRL 6-K 22184
2 ex99-1.htm   iXBRL EX-99.1 613558
3 ex99-1_001.jpg GRAPHIC 1953
4 ex99-2.htm EX-99.2 193199
5 ex99-2_001.jpg GRAPHIC 1953
6 ex99-2_002.jpg GRAPHIC 28737
7 ex99-2_003.jpg GRAPHIC 38982
8 ex99-3.htm EX-99.3 12133
9 ex99-4.htm EX-99.4 17901
  Complete submission text file 0001493152-23-015972.txt   3567563

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE aezs-20230331.xsd EX-101.SCH 32169
11 XBRL CALCULATION FILE aezs-20230331_cal.xml EX-101.CAL 45556
12 XBRL DEFINITION FILE aezs-20230331_def.xml EX-101.DEF 69299
13 XBRL LABEL FILE aezs-20230331_lab.xml EX-101.LAB 225686
14 XBRL PRESENTATION FILE aezs-20230331_pre.xml EX-101.PRE 163729
49 EXTRACTED XBRL INSTANCE DOCUMENT form6-k_htm.xml XML 615120
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 23903113
SIC: 2834 Pharmaceutical Preparations